CannabisNewsBreaks Archive - Page 21 of 429

ThursdaySep 07, 2023 4:49 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 25th Annual Global Investment Conference

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid analogs, today announced its participation in the H.C. Wainwright Global Investment Conference, which is taking place Sept. 11-13, 2023, in New York City. The on-demand presentation by InMed’s CEO Eric A. Adams will be available beginning at 7 a.m. ET on Sept. 11 via webcast, and a recording will also be accessible on InMed’s Investor Relations website for a period of 90 days. In addition, InMed’s management team will be available for one-on-one meetings with registered investors during the conference. Interested…

ThursdaySep 07, 2023 11:54 am

CannabisNewsBreaks – Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquires High Times Intellectual Property, Featured in Financial News Media Article

Lucy Scientific Discovery (NASDAQ: LSDI) today announced the acquisition of the intellectual property (“IP”) of High Times, an iconic brand in the cannabis industry. In addition to the Hightimes.com domain, the transaction also includes the trademarks for the Cannabis Cup and 420.com brands and their respective domain names. In exchange, High Times will receive a 19.9% stake in Lucy's outstanding stock as well as performance-based payments. “Lucy expects this acquisition to drive high margin revenue quickly and sustainably across the cannabis sector around the world. This is a great opportunity to grow the market presence of the nearly 50-year-old High…

WednesdayAug 30, 2023 1:30 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Update on IND Application Progress

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today provided an update on the status of its anticipated submission of an Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”) for the company’s planned U.S. phase 1b hypertension clinical trial designated as HYPER-H23-1. As previously announced, work that was mostly under Lexaria’s control such as batch manufacturing of DehydraTECH(TM)-processed cannabidiol and placebo materials necessary for the IND application filing was completed earlier this year, followed by analytical release and ongoing stability testing. In parallel, the company and its service providers have been…

WednesdayAug 23, 2023 1:49 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes Launching IND Program on DehydraTECH-CBD for Hypertension

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that its groundbreaking research utilizing its patented DehydraTECH(TM)-processed cannabidiol (“DehydraTECH-CBD”) has been published in eight peer-reviewed articles across six different publications. “The most recent publication in June 2023 in the peer-reviewed International Journal of Molecular Sciences is ‘Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study.’ The addition of this research article builds on the growing body of peer-reviewed literature developed by Lexaria’s leading research team into the effects of DehydraTECH-CBD and human health,” a recent article reads. “We’re proud of…

WednesdayAug 23, 2023 1:06 pm

CannabisNewsBreaks – Alt Pro Expo to Take the Spotlight in Vegas

Alternative Products Expo (“Alt Pro Expo”), a renowned pioneer in hosting successful conferences throughout North and South America, today announced details for its upcoming event in the vibrant city of Las Vegas. The Las Vegas Expo 2023 is slated to take place at the expansive World Market Center, the largest event venue in downtown Las Vegas, from Sept. 14-16, 2023. The event has established a reputation as a revolutionary business-networking festival featuring an immense portfolio of innovative alternative products, including vape and hemp products, CBD, disposables, kratom, mushrooms, functional beverages, dietary supplements, nootropics, nicotine replacement, energy enhancers, mood changers and…

MondayAug 21, 2023 3:34 pm

CannabisNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces Results of Annual Meeting

IGC Pharma (NYSE American: IGC) has announced that during its annual meeting of stockholders scheduled for and convened on Aug. 18, 2023, (the “annual meeting”), all proposals as disclosed on the Definitive Proxy Statement on Schedule 14A filed with the SEC on July 26, 2023, were passed by the requisite vote of the stockholders. Only stockholders of record as of the record date of June 21, 2023, were requested to and entitled to vote at the annual meeting. The press release outlines all proposals approved by the requisite vote of the stockholders, which include the election of Claudia Grimaldi to…

TuesdayAug 15, 2023 1:09 pm

CannabisNewsBreaks – GRN Holding Corporation (GRNF), One World Legends Enter Strategic Joint Venture

GRN Holding Corporation (OTC: GRNF) and Marijuana Inc., having recently merged into a consolidated entity, today announced a joint venture with One World Legends (“OWL”), a distinguished player in the cannabis sector. The partnership marks a significant step forward in shaping the future of the cannabis industry and fostering innovation, growth and global collaboration. “We have been working with One World Legends for two years on this project. The joint venture signifies a powerful fusion of expertise, vision and dedication,” said Donald Steinberg, CEO of Marijuana Inc. “OWL has a selection of 17 Landrace strains, which include some famous old…

MondayAug 14, 2023 2:04 pm

CannabisNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Q1 2024 Financial Report

IGC Pharma (NYSE American: IGC), a company that develops advanced cannabinoid-based formulations for treating diseases and conditions, including but not limited to Alzheimer's disease, period cramps (dysmenorrhea), premenstrual syndrome ("PMS") and chronic pain, is reporting on its financial and business results for the first quarter of the 2024 fiscal year, the period ended June 30, 2023. Highlights of the report include a 161% increase in net revenue, which totaled approximately $555,000 compared to $212,000 in the same quarter of 2023; continued momentum in the development of IGC’s phase 3 manufacturing facility located on the West Coast; a $12 million line…

WednesdayAug 09, 2023 12:41 pm

CannabisNewsBreaks – Sustain SoCal Announces IBN as Media Sponsor for Upcoming Annual Water Solution Event

Sustain SoCal, a nonprofit organization, is partnering with IBN (InvestorBrandNetwork), an innovative corporate communications firm and content distributor, for its upcoming annual Water Solutions 8 (“WS8”) event. IBN will serve as media sponsor for the water solutions series, which is returning for the eighth year. The in-person event is scheduled for Aug. 24, 2023, in Irvine, California. According to the announcement, Sustain SoCal has built a reputation “as the leading information hub, advocacy platform and educational forum to improve the discourse and actions on economic progress and sustainable environment in Southern California and the surrounding regions.” This year’s Water Solutions…

WednesdayAug 09, 2023 12:33 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Results from Human Oral Nicotine Study Evaluating DehydraTECH(TM)-Nicotine

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting results from its 2023 human oral nicotine study NIC-H22-1. The study compared Lexaria’s DehydraTECH(TM)-Nicotine tobacco-free pouch to two world-leading brands: ZYN(R) and on!(R) ZYN(R) is from Swedish Match and on! comes from Altria Group Inc. subsidiary Helix Innovations LLC. According to the report, DehydraTECH-Nicotine reached maximum blood saturation levels faster than either of the two other brands. In addition, superior subjective performance characteristics were observed in the study. Specifically, Lexaria’s oral nicotine pouch was significantly faster in the median time required to reach comparable maximum nicotine concentrations…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks